Senior insider sale
President and CEO at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$986.6K
109.50K shares
What this filing means
BOHEN SEAN plans to sell 109.50K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $986.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/11/2024ACC: 0001959173-24-008595
DirectorOfficer· President and CEO
Since Nov 2020
109.50K
Shares to sell
$986.6K
Approx. market value
57.17K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/10/2024
57.17KTotal acquired57.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/10/2024 | Restricted Stock Vesting Compensation | 57.17K | — |
| Total | 57.17K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
52.33K
Market value
$490.2K
12/10/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
57.17K
Market value
$496.3K
12/11/2024
Total
Units
109.50K
Value
$986.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/10/2024 | 52.33K | $490.2K | — | Completed |
| Planned — Approximate Date | ||||
12/11/2024 | 57.17K | $496.3K | NASDAQ | Planned |
| Total | 109.50K | $986.6K | ||